Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs CC in IUI for Endometriosis
NCT01334762Phase 2
Key facts
- Status
- Completed
- Start
- May 2007
- Primary completion
- Jun 2010
- Countries
- 1
- Sponsor
- Mansoura University
- Modality
- Orthosteric Ligands
- Drugs
- letrozole
- Conditions
- female infertility
01
Overview
Phase 2, randomised, single-blind trial of letrozole in female infertility (2 arms), sponsored by Mansoura University. Primary endpoint: Clinical pregnancy rate per cycle. Started May 2007; status: completed.
02
Design
2 arms- Study design
- RandomizedSingle-blind
Letrozole/IUI
Letrozole 5 mg daily for 5 days + IUI
CC/IUI
Clomiphene Citrate 100 mg daily for 5 days + IUI
03
Who it enrols
Women with minimal-mild endometriosis recently treated by laparoscopy (6-12 months prior), no other infertility factors, normal basal hormones and documented ovulation. Excludes moderate/severe endometriosis, dense adhesions, age > 36, BMI > 30, and previous pregnancy.
04
Endpoints
Primary
Clinical pregnancy rate per cycle
Secondary
Miscarriage rate
Beyond the preview
Go deeper on NCT01334762.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01334762.